Single-Chamber Prefilled Syringes Global Market Report 2024

Single-chamber prefilled syringes refer to a type of syringe where the substance to be injected is pre-filled, and they contain only a single type of substance.

The primary types of products in the category of single-chamber prefilled syringes include those made of glass and plastic. Glass-based single-chamber prefilled syringes are manufactured using glass, which is a commonly preferred material for such syringes. Plastic-based single-chamber prefilled syringes, on the other hand, utilize plastic as the preferred material. These syringes are designed for the injection of pre-filled vaccine products, biological substances, or pharmaceutical products.

The single-chamber prefilled syringes market research report is one of a series of new reports that provides single-chamber prefilled syringes market statistics, including single-chamber prefilled syringes industry global market size, regional shares, competitors with a single-chamber prefilled syringes market share, detailed single-chamber prefilled syringes market segments, market trends and opportunities, and any further data you may need to thrive in the single-chamber prefilled syringes industry. This single-chamber prefilled syringes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The single-chamber prefilled syringes market size has grown rapidly in recent years. It will grow from $9.74 billion in 2023 to $11 billion in 2024 at a compound annual growth rate (CAGR) of 13.0%. The growth observed in the historical period can be attributed to various factors, including advancements and growth in the pharmaceutical and biotechnology sectors, the emphasis on patient-friendly drug administration methods, the focus on safety and ease of use in drug delivery, the demand for precise drug dosing, and adherence to regulatory approvals and guidelines in the healthcare industry.

The single-chamber prefilled syringes market size is expected to see rapid growth in the next few years. It will grow to $19.22 billion in 2028 at a compound annual growth rate (CAGR) of 15.0%. The anticipated growth in the forecast period can be attributed to various factors, including the increasing use of prefilled syringes for biologics and biosimilars, the rise in self-administration and home healthcare practices, the focus on pediatric and geriatric drug delivery solutions, the development of combination products with auto-injectors, the regulatory emphasis on drug safety, and the growth of telemedicine and remote monitoring in healthcare. Key trends expected in the forecast period include the incorporation of connected devices with prefilled syringes, the adoption of sustainable and biodegradable materials in syringe manufacturing, the availability of customized and patient-specific syringe options, the integration of needlestick prevention and safety features, the application of prefilled syringes in the delivery of cell and gene therapies, and the implementation of anti-counterfeiting measures in prefilled syringe design.

The rising incidence of chronic diseases like diabetes and cancer is fueling the growth of the single-chamber prefilled syringe market. Individuals with diabetes, particularly those requiring insulin therapy, rely on single-chamber prefilled syringes when conventional medications fail to manage their blood glucose levels. According to the IDF Diabetes Atlas 2021, approximately 1 in 10 people (20–79 years old) worldwide, totaling 537 million individuals, are affected by diabetes, with projections indicating an increase to 643 million by 2030 and 783 million by 2045. Simultaneously, the American Cancer Society reports an expected 1.9 million new cancer cases in 2021. Consequently, the expanding prevalence of chronic diseases, such as diabetes and cancer, is a significant driver for the single-chamber prefilled syringe market.

The growing number of clinical trials is anticipated to drive the future growth of the single-chamber prefilled syringe market. Clinical trials, essential for evaluating the safety and effectiveness of new medical treatments, interventions, or drugs, require standardized and secure drug administration methods. Single-chamber prefilled syringes play a vital role in clinical trials by offering a safe and efficient means of drug delivery to research participants. Notably, the number of registered studies increased to 464,218 in August 2023 compared to 399,496 in 2021, according to ClinicalTrials.gov, covering all 50 states in the United States and 221 countries worldwide. The rising participation in clinical trials, with 31% in the U.S. and 53% in non-U.S. locations, is poised to be a significant factor propelling the single-chamber prefilled syringes market.

Technological advancements are shaping the landscape of the single-chamber prefilled syringe market. Leading companies in this sector are actively engaged in developing technological solutions to strengthen their market presence. For example, in September 2022, Otsuka America Pharmaceutical, Inc., and H. Lundbeck A/S introduced Aripiprazole 2-month, a ready-to-use, long-acting injectable form of aripiprazole delivered through a single-chamber prefilled syringe. The injection, designed for intramuscular administration every two months, offers a technologically advanced solution in the market.

Major industry players are strategically focusing on the development of generic injectable medicines like succinylcholine chloride injections to expand their product offerings. Succinylcholine Chloride Injection, available in prefilled syringe format, is prepared for direct intravenous or intramuscular dosing during surgery and ventilation without requiring dilution. Hikma Pharmaceuticals PLC, a multinational pharmaceutical company, introduced the first FDA-approved prefilled syringe for Succinylcholine Chloride Injection in the US market in October 2022.

In January 2022, Nordic Pharma Group acquired the ALTIM (cortivazol) prefilled syringe from Sanofi S.A. This strategic move aligns with Nordic Pharma's objectives of portfolio expansion and establishing a prominent position in rheumatology, with ALTIM being a prefilled syringe containing a 3.75 mg/1.5 ml cortivazol suspension for injection.

Major companies operating in the single-chamber prefilled syringes market include Becton, Dickinson and Company, Gerresheimer Glass Inc., Schott AG, Catalent Inc., Nipro Medical Corporation, Weigao Group Medical Polymer Company Limited, Stevanato Group S.p.A., Baxter International Inc., Vetter Pharma International GmbH, Terumo Corporation, Ypsomed Holding AG, SHL Medical AG, Ompi, Elcam Medical A.C.S. Ltd., Oval Medical Technologies Ltd., West Pharmaceutical Services Inc., Gerresheimer Regensburg GmbH, SCHOTT North America Inc., Vetter Pharma-Fertigung GmbH & Co. KG, Aptar Pharma Services Inc., Bespak Europe Ltd., Credence MedSystems Inc., Datwyler Pharma Packaging International Holding AG, Dätwyler Sealing Solutions AG, Fresenius Kabi AG, Haselmeier GmbH, Hikma Pharmaceuticals PLC, HTL-STREFA S.A., Intas Pharmaceuticals Ltd.

North America was the largest region in the single-chamber prefilled syringes market in 2023. Asia-Pacific was the second largest region in the single-chamber prefilled syringes market share. The regions covered in the single-chamber prefilled syringes market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the single-chamber prefilled syringes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The single-chamber prefilled syringes market consists of sales of glass and plastic single-chamber prefilled syringes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.